EVoE System Commercialization

About Hermes Biosciences

Hermes Biosciences is a private, pre-revenue platform company commercializing the EVoE System, an automated benchtop instrument for isolating extracellular vesicles. The technology, licensed from Stanford University and based on the ExoTIC (exosome total isolation chip) nanofiltration method, is designed to overcome the yield, purity, and reproducibility challenges that have hindered EV research and therapeutic development. With a recently closed seed funding round, the company is positioned to scale its technology to accelerate biomarker discovery and the development of EV-based diagnostics and therapeutics, targeting a significant and growing market in precision medicine.

Therapeutic Areas